N Acetyl Cysteine for Cystinosis Patients

Status Completed

Clinical Trial Summary

This study intends to verify the interference of N acetyl cysteine in the progression of chronic kidney disease in patients with Nephropathic Cystinosis.

Clinical Trial Description

Patients with Nephropathic Cystinosis have an increased oxidative stress and go to end-stage renal disease, even when all steps of the treatment are done. Therefore, this study is conducted to verify the interference of the stress oxidative in the progression of the renal disease with the use of an oxidant drug, N acetyl cysteine (NAC). The investigators selected patients with good compliance of the treatment. In these patients the investigators evaluate the serum creatinine, creatinine clearance estimated by Schwartz Formula, cystatin C and a marker of oxidative stress, TBARS ( thiobarbituric acid substances). The variables are analyzed 6 months before the introduction of NAC and the three months after NAC. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01614431
Study type	Interventional
Source	University of Sao Paulo
Contact
Status	Completed
Phase	Phase 4
Start date	March 2011
Completion date	May 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03672110` - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen	Phase 3
Completed	`NCT01545531` - Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance	N/A
Recruiting	`NCT05700903` - Contributions to Hypertension With Androgen Deprivation Therapy	Phase 4
Completed	`NCT03717883` - ADPKD Alterations in Hepatic Transporter Function
Withdrawn	`NCT04556721` - A Pharmacokinetic Study of Sugammadex in Dialysis Patients	Phase 1
Active, not recruiting	`NCT04078750` - PLATO - Medication Adherence in Transplant Recipients	N/A
Not yet recruiting	`NCT04531124` - Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
Completed	`NCT03107195` - Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging
Completed	`NCT03463148` - Validation of a Sensor for Non-Invasive Measurements
Recruiting	`NCT03578523` - Renal MR Feasibility in Renal Disease
Withdrawn	`NCT01468259` - A Multi-Center, Open-Label Study	Phase 1
Completed	`NCT01256983` - Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation	Phase 0
Completed	`NCT06070337` - H-Guard Pilot Safety Evaluation in Haemodialysis Patients	N/A
Completed	`NCT05593211` - Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures	N/A
Completed	`NCT03242343` - VasQ External Support for Arteriovenous Fistula	N/A
Completed	`NCT03438123` - Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera	N/A
Completed	`NCT01334333` - Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients	Phase 4
Recruiting	`NCT05443321` - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes	N/A
Completed	`NCT04407182` - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19	Phase 2
Not yet recruiting	`NCT06419270` - Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism